You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NF Type 1 - low grade glioma - not responded to treatments

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)

Recruiting
  • Grade 1 Glioma
  • +2 more
  • Strasbourg, France
    CHU Strasbourg - France
Jul 7, 2022

NF1, Low-grade Glioma Trial in United States (Poly ICLC)

Recruiting
  • NF1
  • Low-grade Glioma
  • Poly ICLC
  • Birmingham, Alabama
  • +18 more
Jan 5, 2023

Frameshift Peptides of Children With NF1

Completed
  • Neurofibromatosis Type 1
  • Frameshift Array blood sample test
  • Washington, District of Columbia
  • +2 more
Aug 29, 2022

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

Recruiting
  • Recurrent Low Grade Astrocytoma
  • +4 more
  • Quality-of-Life Assessment
  • +3 more
  • Birmingham, Alabama
  • +64 more
Aug 20, 2022

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

Recruiting
  • Low Grade Glioma
  • +2 more
  • Birmingham, Alabama
  • +120 more
Jan 27, 2023

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Low-grade Glioma Trial in Toronto (Saturation Transfer (ST)-MRI)

Recruiting
  • Low-grade Glioma
  • Saturation Transfer (ST)-MRI
  • Toronto, Ontario, Canada
  • +1 more
Aug 10, 2023

A Living Tissue Bank of Patient-Derived Organoids From Glioma

Active, not recruiting
  • Low-grade Glioma
  • High Grade Glioma
    • Maastricht, Limburg, Netherlands
      Maastricht Radiation Oncology
    Aug 23, 2022

    Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

    Recruiting
    • Low-Grade Glioma
    • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 24, 2022

    Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

    Not yet recruiting
    • Low Grade Glioma
    • model-guided optimization of treatment plan
    • standard treatment plan, no optimization
    • Heidelberg, Germany
      Department of Radiotherapy, University of Heidelberg
    Jul 19, 2023

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Brain Cancer Trial in Lebanon (Fluorescein, Fluorescein + ALA)

    Recruiting
    • Brain Cancer
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Aug 2, 2022

    Glioma Trial in Boston (Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt)

    Not yet recruiting
    • Glioma
    • Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt
    • Boston, Massachusetts
      Tufts Medical Center
    Dec 8, 2022

    Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

    Active, not recruiting
    • Low-Grade Gliomas
    • +2 more
    • Birmingham, Alabama
    • +14 more
    Jan 25, 2023

    Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

    Active, not recruiting
    • Malignant Glioma
    • +2 more
    • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
    • Concurrent Optune and RT followed by Optune System alone
    • Los Angeles, California
    • +8 more
    Jan 17, 2023

    Glioma Trial in United States (RAD001 (Everolimus))

    Completed
    Has Results
    • Glioma
    • RAD001 (Everolimus)
    • Los Angeles, California
    • +11 more
    Jan 31, 2020

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))

    Active, not recruiting
    • Glioma
    • Glioblastoma
    • Focused ultrasound (FUS)
    • Baltimore, Maryland
    • +3 more
    Sep 8, 2022

    Glioma Trial in Montpellier (Blood samples)

    Recruiting
    • Glioma
    • Blood samples
    • Montpellier, France
      University Hospital, Montpellier
    Feb 9, 2022

    Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

    Not yet recruiting
    • Low-grade Glioma
    • (no location specified)
    Oct 3, 2022

    Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

    Not yet recruiting
    • Optic Pathway Glioma
    • Rome, Italy
      Catholic University, Policlinico A. Gemelli (Hospital)
    Feb 17, 2023

    Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas Trial in United States (Everolimus)

    Active, not recruiting
    Has Results
    • Pediatric Recurrent Progressive Low-grade Gliomas
    • Pediatric Progressive Low-grade Gliomas
    • Los Angeles, California
    • +17 more
    Jun 27, 2022